Related Articles
Bioinformatics analysis of gene expression alterations conferring drug resistance in tumor samples from melanoma patients with EGFR-activating BRAF mutations
Comparative efficiency of differential diagnostic methods for the identification of BRAF V600E gene mutation in papillary thyroid cancer (Review)
Intra‑tumor heterogeneity of BRAF V600E mutation in lung adenocarcinomas
Prognostic implications of the BRAF‑V600E mutation in papillary thyroid carcinoma based on a new cut‑off age stratification
EGFR inhibition enhances the antitumor efficacy of a selective BRAF V600E inhibitor in thyroid cancer cell lines